Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis

BACKGROUND: Numerous studies have demonstrated the potential of pirfenidone to enhance the prognosis of patients afflicted with idiopathic pulmonary fibrosis (IPF). Although N-acetylcysteine (NAC) is utilized as an antioxidant in IPF treatment, the combination of NAC and pirfenidone has produced inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiu-Li, Cao, Ying, Zheng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685588/
https://www.ncbi.nlm.nih.gov/pubmed/38031002
http://dx.doi.org/10.1186/s12890-023-02778-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685588/
https://www.ncbi.nlm.nih.gov/pubmed/38031002
http://dx.doi.org/10.1186/s12890-023-02778-w

Ejemplares similares